Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels

Standards of Medical Care in Diabetes—2010

Diabetes Care · 2009 · 3.5K citations · Full text

Medicine, Health Policy, Internal Medicine +12

Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes

Joachim Spranger, Anja Kroke, Matthias Möhlig et al. · Diabetes · 2003 · 1.5K citations · Full text

Medicine, Endocrinology, Immunology +15

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

John C. Pickup, M. Mattock, Gary Chusney et al. · Diabetologia · 1997 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +16

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes

Andreas Festa, Ralph B. D’Agostino, Russell P. Tracy et al. · Diabetes · 2002 · 1.1K citations · Full text

Medicine, Physiology, Diabetology +15

Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction

Meena S. Madhur, Heinrich E. Lob, Louise McCann et al. · Hypertension · 2009 · 818 citations · Full text

Veterinary Medicine, Cardiology, Immunology +17